CLEC9A and neoplasm: cDC1s express a range of proteins that have been shown to be involved in the cross‐presentation of cellular antigens, such as DNGR‐1 (a.k.a CLEC9A) and WDFY4, both of which are crucial for anti‐tumour immunity in murine tumour models [3, 4].